Kohji Ohki Selected Research

Kohji Ohki Research Topics

Disease

9	Hypertension (High Blood Pressure) 01/2019 - 01/2005
5	Fibrosis (Cirrhosis) 01/2020 - 07/2017
4	Albuminuria 01/2019 - 12/2015
4	Chronic Renal Insufficiency 01/2017 - 12/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2020 - 03/2017
3	Abdominal Obesity 12/2018 - 01/2014
3	Hypertrophy 01/2018 - 01/2014
2	Body Weight (Weight, Body) 01/2020 - 01/2014
2	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2019
2	Insulin Resistance 12/2018 - 03/2017
2	Cognitive Dysfunction 02/2018 - 07/2015
2	Obesity 03/2017 - 05/2015
2	Dyslipidemias (Dyslipidemia) 01/2017 - 12/2015
2	Atherosclerosis 08/2014 - 05/2013
1	Anemia 07/2020
1	Ureteral Obstruction 01/2020
1	Protein Deficiency 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dementia (Dementias) 02/2018
1	Pathologic Neovascularization 01/2018
1	Hypercholesterolemia 05/2013
1	Dermatitis 01/2010
1	Experimental Arthritis 08/2008
1	Rheumatoid Arthritis 08/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2007
1	Hyperemia 06/2007

Drug/Important Bio-Agent (IBA)

6	Angiotensin IIIBA 01/2019 - 01/2014
5	Type 1 Angiotensin ReceptorIBA 01/2022 - 01/2017
4	Therapeutic UsesIBA 01/2020 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2014
3	Peptides (Polypeptides)IBA 02/2018 - 09/2011
3	indolepropanol phosphate (IPP)IBA 05/2013 - 06/2007
3	casein hydrolysateIBA 08/2008 - 01/2005
2	liu-jun-zi-tangIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 12/2015
2	Angiotensin Receptor AntagonistsIBA 01/2016 - 01/2014
2	Peptide Hydrolases (Proteases)FDA Link 08/2008 - 01/2005
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	continuous erythropoietin receptor activator FDA Link 07/2020
1	Darbepoetin alfa (Aranesp)FDA Link 07/2020
1	Erythropoietin FDA Link 07/2020
1	GhrelinIBA 01/2020
1	Sirtuin 1IBA 11/2019
1	AngiotensinsIBA 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	CollagenIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	NitrogenIBA 01/2019
1	dapagliflozinIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	AdipokinesIBA 03/2017
1	CholesterolIBA 01/2017
1	aliskiren FDA Link 01/2016
1	Renin InhibitorsIBA 01/2016
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2016
1	Irbesartan FDA LinkGeneric 01/2016
1	pitavastatin (itavastatin)FDA Link 12/2015
1	pentosidineIBA 12/2015
1	LipidsIBA 12/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015
1	oxidized low density lipoproteinIBA 12/2015
1	Scopolamine (Hyoscine)FDA Link 07/2015
1	PowdersIBA 07/2015
1	bofu-tsusho-sanIBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	olmesartanIBA 01/2014
1	isoleucyl-prolyl-prolineIBA 05/2013
1	ApolipoproteinsIBA 05/2013
1	Apolipoproteins E (ApoE)IBA 05/2013
1	valyl-prolyl-prolineIBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	Caseins (Casein)FDA Link 09/2011
1	SolutionsIBA 01/2010
1	SodiumIBA 01/2010
1	Antihypertensive Agents (Antihypertensives)IBA 01/2005

Therapy/Procedure

3	Therapeutics 01/2016 - 05/2015
1	Lasers (Laser) 01/2018
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2017
1	Nephrectomy 01/2017
1	Diet Therapy (Therapy, Diet) 12/2015